Dispensing patterns of antimigraine agents with a focus on seasonal variations in prescribing
Résumé
Purpose: To determine the dispensing patterns of antimigraine agents in a private healthcare setting, focusing on seasonal variations in prescribing.Methods: A retrospective, cross-sectional drug utilization study was conducted using a South African medical insurance scheme administrator database for 2016. The database contained 3 567 170 records for medicines, medical devices and procedures. All products in MIMS category 1.9 (antimigraine agents) were analysed.Results: A total of 914 antimigraine products were dispensed to 505 patients (69.70 % females) at a cost of US$10,988.63. The average age of patients was 41.57 (SD = 13.77) years. Of the eight active ingredients, clonidine was the most often dispensed (34.68 %), followed by rizatriptan (28.01 %) and ergotamine (26.04 %). Prescribing peaks were observed in February to April 2016, and again in October. These months coincide with the change in seasons to winter and to summer, respectively, in South Africa.Conclusion: The sample size was too small to make definite conclusions, but it seems that prescribing of antimigraine agents reaches a peak during seasonal change specifically autumn and spring, confirming that weather is a possible trigger factor in migraine.Keywords: Migraine, Antimigraine agents, Trigger factors, Environmental, Weather, Seasonal, Prescribing patterns, Rizatriptan
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 30/08/2026. Le document reste hébergé par sa source.
Voir le document à la source →